MSD recruits Promega for Keytuda companion diagnostic
admin 8th November 2019 Uncategorised 0Keytruda is predicted to be the best-selling drug by annual revenue in 2023. More: MSD recruits Promega for Keytuda companion diagnostic Source: News
read more